Cargando…

Pathogenic Interleukin-10 Receptor Alpha Variants in Humans — Balancing Natural Selection and Clinical Implications

Balancing natural selection is a process by which genetic variants arise in populations that are beneficial to heterozygous carriers, but pathogenic when homozygous. We systematically investigated the prevalence, structural, and functional consequences of pathogenic IL10RA variants that are associat...

Descripción completa

Detalles Bibliográficos
Autores principales: Aschenbrenner, Dominik, Ye, Ziqing, Zhou, Ying, Hu, Wenhui, Brooks, Isabel, Williams, Isabelle, Capitani, Melania, Gartner, Lisa, Kotlarz, Daniel, Snapper, Scott B., Klein, Christoph, Muise, Aleixo M., Marsden, Brian D., Huang, Ying, Uhlig, Holm H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892166/
https://www.ncbi.nlm.nih.gov/pubmed/36370291
http://dx.doi.org/10.1007/s10875-022-01366-7
_version_ 1784881290385817600
author Aschenbrenner, Dominik
Ye, Ziqing
Zhou, Ying
Hu, Wenhui
Brooks, Isabel
Williams, Isabelle
Capitani, Melania
Gartner, Lisa
Kotlarz, Daniel
Snapper, Scott B.
Klein, Christoph
Muise, Aleixo M.
Marsden, Brian D.
Huang, Ying
Uhlig, Holm H.
author_facet Aschenbrenner, Dominik
Ye, Ziqing
Zhou, Ying
Hu, Wenhui
Brooks, Isabel
Williams, Isabelle
Capitani, Melania
Gartner, Lisa
Kotlarz, Daniel
Snapper, Scott B.
Klein, Christoph
Muise, Aleixo M.
Marsden, Brian D.
Huang, Ying
Uhlig, Holm H.
author_sort Aschenbrenner, Dominik
collection PubMed
description Balancing natural selection is a process by which genetic variants arise in populations that are beneficial to heterozygous carriers, but pathogenic when homozygous. We systematically investigated the prevalence, structural, and functional consequences of pathogenic IL10RA variants that are associated with monogenic inflammatory bowel disease. We identify 36 non-synonymous and non-sense variants in the IL10RA gene. Since the majority of these IL10RA variants have not been functionally characterized, we performed a systematic screening of their impact on STAT3 phosphorylation upon IL-10 stimulation. Based on the geographic accumulation of confirmed pathogenic IL10RA variants in East Asia and in Northeast China, the distribution of infectious disorders worldwide, and the functional evidence of IL-10 signaling in the pathogenesis, we identify Schistosoma japonicum infection as plausible selection pressure driving variation in IL10RA. Consistent with this is a partially augmented IL-10 response in peripheral blood mononuclear cells from heterozygous variant carriers. A parasite-driven heterozygote advantage through reduced IL-10 signaling has implications for health care utilization in regions with high allele frequencies and potentially indicates pathogen eradication strategies that target IL-10 signaling. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10875-022-01366-7.
format Online
Article
Text
id pubmed-9892166
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-98921662023-02-03 Pathogenic Interleukin-10 Receptor Alpha Variants in Humans — Balancing Natural Selection and Clinical Implications Aschenbrenner, Dominik Ye, Ziqing Zhou, Ying Hu, Wenhui Brooks, Isabel Williams, Isabelle Capitani, Melania Gartner, Lisa Kotlarz, Daniel Snapper, Scott B. Klein, Christoph Muise, Aleixo M. Marsden, Brian D. Huang, Ying Uhlig, Holm H. J Clin Immunol Original Article Balancing natural selection is a process by which genetic variants arise in populations that are beneficial to heterozygous carriers, but pathogenic when homozygous. We systematically investigated the prevalence, structural, and functional consequences of pathogenic IL10RA variants that are associated with monogenic inflammatory bowel disease. We identify 36 non-synonymous and non-sense variants in the IL10RA gene. Since the majority of these IL10RA variants have not been functionally characterized, we performed a systematic screening of their impact on STAT3 phosphorylation upon IL-10 stimulation. Based on the geographic accumulation of confirmed pathogenic IL10RA variants in East Asia and in Northeast China, the distribution of infectious disorders worldwide, and the functional evidence of IL-10 signaling in the pathogenesis, we identify Schistosoma japonicum infection as plausible selection pressure driving variation in IL10RA. Consistent with this is a partially augmented IL-10 response in peripheral blood mononuclear cells from heterozygous variant carriers. A parasite-driven heterozygote advantage through reduced IL-10 signaling has implications for health care utilization in regions with high allele frequencies and potentially indicates pathogen eradication strategies that target IL-10 signaling. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10875-022-01366-7. Springer US 2022-11-12 2023 /pmc/articles/PMC9892166/ /pubmed/36370291 http://dx.doi.org/10.1007/s10875-022-01366-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Aschenbrenner, Dominik
Ye, Ziqing
Zhou, Ying
Hu, Wenhui
Brooks, Isabel
Williams, Isabelle
Capitani, Melania
Gartner, Lisa
Kotlarz, Daniel
Snapper, Scott B.
Klein, Christoph
Muise, Aleixo M.
Marsden, Brian D.
Huang, Ying
Uhlig, Holm H.
Pathogenic Interleukin-10 Receptor Alpha Variants in Humans — Balancing Natural Selection and Clinical Implications
title Pathogenic Interleukin-10 Receptor Alpha Variants in Humans — Balancing Natural Selection and Clinical Implications
title_full Pathogenic Interleukin-10 Receptor Alpha Variants in Humans — Balancing Natural Selection and Clinical Implications
title_fullStr Pathogenic Interleukin-10 Receptor Alpha Variants in Humans — Balancing Natural Selection and Clinical Implications
title_full_unstemmed Pathogenic Interleukin-10 Receptor Alpha Variants in Humans — Balancing Natural Selection and Clinical Implications
title_short Pathogenic Interleukin-10 Receptor Alpha Variants in Humans — Balancing Natural Selection and Clinical Implications
title_sort pathogenic interleukin-10 receptor alpha variants in humans — balancing natural selection and clinical implications
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892166/
https://www.ncbi.nlm.nih.gov/pubmed/36370291
http://dx.doi.org/10.1007/s10875-022-01366-7
work_keys_str_mv AT aschenbrennerdominik pathogenicinterleukin10receptoralphavariantsinhumansbalancingnaturalselectionandclinicalimplications
AT yeziqing pathogenicinterleukin10receptoralphavariantsinhumansbalancingnaturalselectionandclinicalimplications
AT zhouying pathogenicinterleukin10receptoralphavariantsinhumansbalancingnaturalselectionandclinicalimplications
AT huwenhui pathogenicinterleukin10receptoralphavariantsinhumansbalancingnaturalselectionandclinicalimplications
AT brooksisabel pathogenicinterleukin10receptoralphavariantsinhumansbalancingnaturalselectionandclinicalimplications
AT williamsisabelle pathogenicinterleukin10receptoralphavariantsinhumansbalancingnaturalselectionandclinicalimplications
AT capitanimelania pathogenicinterleukin10receptoralphavariantsinhumansbalancingnaturalselectionandclinicalimplications
AT gartnerlisa pathogenicinterleukin10receptoralphavariantsinhumansbalancingnaturalselectionandclinicalimplications
AT kotlarzdaniel pathogenicinterleukin10receptoralphavariantsinhumansbalancingnaturalselectionandclinicalimplications
AT snapperscottb pathogenicinterleukin10receptoralphavariantsinhumansbalancingnaturalselectionandclinicalimplications
AT kleinchristoph pathogenicinterleukin10receptoralphavariantsinhumansbalancingnaturalselectionandclinicalimplications
AT muisealeixom pathogenicinterleukin10receptoralphavariantsinhumansbalancingnaturalselectionandclinicalimplications
AT marsdenbriand pathogenicinterleukin10receptoralphavariantsinhumansbalancingnaturalselectionandclinicalimplications
AT huangying pathogenicinterleukin10receptoralphavariantsinhumansbalancingnaturalselectionandclinicalimplications
AT uhligholmh pathogenicinterleukin10receptoralphavariantsinhumansbalancingnaturalselectionandclinicalimplications